Evidence of Off-Label Drug Use to Reduce Dementia

1,902
Total downloads
7,202
Total views and downloads

Articles

BRIEF RESEARCH REPORT

Published on 22 Jul 2024

Wnt/β-catenin pathway as a potential target for Parkinson’s disease: a cohort study of romosozumab using routinely collected health data in Japan

Shoichiro Inokuchi
Koji Shimamoto

doi 10.3389/fphar.2024.1411285

1,673 views
1 citation

ORIGINAL RESEARCH

Published on 17 Jul 2024

Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

Yihan Yang
Sheng Wei
Huan Tian
Jing Cheng
Yue Zhong
Xiaoling Zhong
Dunbing Huang
Cai Jiang
Xiaohua Ke

doi 10.3389/fphar.2024.1439115

3,707 views
8 citations

Share on

Frontiers in Dementia

Frontiers in Dementia

Translational Research in Dementia

Participating Journals

Frontiers in Neurology
- Experimental Therapeutics
- 2.8 impact factor
- 5.2 citescore
Frontiers in Neuroscience
- Neuropharmacology
- 3.2 impact factor
- 6.6 citescore
Frontiers in Pharmacology
- Neuropharmacology
- 4.8 impact factor
- 8.9 citescore
Frontiers in Psychiatry
- Psychopharmacology
- 3.2 impact factor
- 6.2 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

7,202Topic views
4,096Article views
1,902Article downloads